INS and Hypoglycemia: Empagliflozin has several adverse effects to be monitored for, including hypotension, ketoacidosis, acute kidney injury, genital mycotic infections, hypoglycemia when combined with insulin, a rare but serious Fournier gangrene, and pyelonephritis [18].